Trials / Sponsors / SignalChem Lifesciences Corporation
SignalChem Lifesciences Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic | Phase 1 / Phase 2 | 2023-05-31 |
| Completed | Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of SLC-391 in Healthy Adult Subjects Food-drug Interaction | Phase 1 | 2022-02-12 |
| Completed | Safety Study of SLC-391 in Subjects With Solid Tumors Solid Tumor | Phase 1 | 2019-09-17 |